(Q54419170)

29 May 2018

title

Amantadine in Parkinsonism. (English)

1 reference

29 May 2018

1 reference

J Pearce

1

1 reference

29 May 2018

N S Rao

series ordinal

2

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 November 1970

1 reference

29 May 2018

published in

The Lancet

1 reference

29 May 2018

volume

2

1 reference

29 May 2018

issue

7682

1 reference

29 May 2018

page(s)

1091-1092

1 reference

29 May 2018

Controlled trial of amantadine hydrochloride in Parkinson's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2990332-6

7 January 2021

Amantadine dosage in treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2990332-6

7 January 2021

Amantadine in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2990332-6

7 January 2021

Amantadine in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2990332-6

7 January 2021

Effects of withdrawing dopa in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2990332-6

7 January 2021

Effect of Thymectomy in Adult Mice on Immunological Responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2990332-6

7 January 2021

The effect of adult thymectomy on the immunosuppression obtained by treatment with antilymphocyte serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2990332-6

7 January 2021

10.1016/S0140-6736(70)90332-6

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

4098392

1 reference

29 May 2018